Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 26;10(6):434.
doi: 10.3390/diagnostics10060434.

Molecular and Serological Tests for COVID-19 a Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics

Affiliations
Review

Molecular and Serological Tests for COVID-19 a Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics

Robert Kubina et al. Diagnostics (Basel). .

Abstract

Validated and accurate laboratory testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a crucial part of the timely management of Coronavirus Disease 2019 (COVID-19) disease, supporting the clinical decision-making process for infection control at the healthcare level and detecting asymptomatic cases. This would facilitate an appropriate treatment, a prompt isolation and consequently deceleration of the pandemic. Various laboratory tests can identify the genetic material of SARS-CoV-2 that causes COVID-19 in specimens, or specific anti-viral antibodies in blood/serum. Due to the current pandemic situation, a development of point-of-care diagnostics (POCD) allows us to substantially accelerate taking clinical decisions and implement strategic planning at the national level of preventative measures. This review summarizes and compares the available POCD and those currently under development, including quantitative reverse transcription PCR (RT-qPCR), serology immunoassays (SIAs) and protein microarray method (PMM) designed for standard and rapid COVID-19 diagnosis.

Keywords: COVID-19; RT-qPCR; SARS-CoV-2; in vitro diagnostic tests; serology immunoassays.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Real Time PCR COVID-19 genetic tests detecting ORF1ab, spike (S), envelope (E), or nucleocapsid (N) gene sequences of SARS-CoV-2 coronavirus (own interpretation, based on [8]).

Similar articles

Cited by

References

    1. Lau S.K.P., Woo P.C.Y., Yip C.C.Y., Tse H., Tsoi H., Cheng V.C.C., Lee P., Tang B.S.F., Cheung C.H.Y., Lee R.A., et al. Coronavirus HKU1 and Other Coronavirus Infections in Hong Kong. J. Clin. Microbiol. 2006;44:2063–2071. doi: 10.1128/JCM.02614-05. - DOI - PMC - PubMed
    1. Singhal T. A Review of Coronavirus Disease-2019 (COVID-19) Indian J. Pediatr. 2020;87:281–286. doi: 10.1007/s12098-020-03263-6. - DOI - PMC - PubMed
    1. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) [(accessed on 13 June 2020)]; Available online: https://coronavirus.jhu.edu/map.html.
    1. World Health Organization Advice on the Use of Point-Of-Care Immunodiagnostic Tests for COVID-19. [(accessed on 13 June 2020)]; Available online: https://www.who.int/news-room/commentaries/detail/advice-on-the-use-of-p....
    1. Corman V., Bleicker T., Brünink S., Drosten C., Landt O., Koopmans M., Zambon M. Diagnostic Detection of 2019-nCoV by Real-Time RT-PCR. [(accessed on 23 June 2020)]; Protocol and Preliminary Evaluationas of 17 January 2020. Available online: https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?s...

LinkOut - more resources